Company: VLDXW
Filing Date: 2025-04-30
Form Type: DEF 14A
Source: 0000950170-25-060611
Chunk: 36

Company: Velo3D, Inc.
Filing Date: 2025-04-30
Form: DEF 14A
Chunk 36
---
 another entity. We must indemnify our officers and directors against all reasonable fees, expenses, charges and other costs of any type or nature whatsoever, including any and all expenses and obligations paid or incurred in connection with investigating, defending, being a witness in, participating in (including on appeal), or preparing to defend, be a witness or participate in any completed, actual, pending or threatened action, suit, claim or proceeding, whether civil, criminal, administrative or investigative, or establishing or enforcing a right to indemnification under the indemnification agreement.

<div align='center'>30</div>

EQUITY COMPENS A TION PLAN INFORMATION The following table presents information as of December 31, 2024 with respect to compensation plans under which shares of our common stock may be issued.

| Plan category                                              |     | Number of      
 securities     
 to be issued   
 upon exercise  
 of outstanding 
 securities (#) 
 (a)            |         |     | Weighted-      
 average        
 exercise price 
 of outstanding 
 options ($)    
 (b)            |       |     | Number of        
 securities       
 remaining        
 available for    
 future issuance  
 under equity     
 compensation     
 plans (excluding 
 securities       
 reflected in     
 column(a))(#)    
 (c)              |         |
|:-----------------------------------------------------------|:----|:---------------|--------:|:----|:---------------|------:|:----|:-----------------|--------:|
| Equity compensation plans approved by security holders     |     |                | 476,742 |     | $              | 25.38 |     |                  | 196,213 |
| Equity compensation plans not approved by security holders |     |                |       — |     |                |     — |     |                  |       — |
| Total                                                      |     |                | 476,742 |     | $              | 25.38 |     |                  | 196,213 |

(1) The weighted-average exercise price does not reflect the shares that will be issued in connection with the settlement of RSUs, since RSUs have no exercise price. (2) Includes (i) the 2021 EIP, and (ii) the 2021 Employee Stock Purchase Plan ('ESPP'). (3) Includes 476,742 shares subject to outstanding awards granted under the 2021 EIP, of which 270,529 shares were subject to outstanding options and 196,213 shares were subject to outstanding RSU awards. (4) As of December 31,